Russell Investments Group, Ltd. Rigel Pharmaceuticals Inc Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$1.12 - $1.57 $31,472 - $44,117	-28,100 Reduced 19.3%	117,459 $173,000
Q4 2023 Feb 05, 2024	SELL	$0.72 - $1.56 $34,357 - $74,441	-47,719 Reduced 24.69%	145,559 $211,000
Q3 2023 Nov 13, 2023	SELL	$1.07 - $1.39 $19,159 - $24,889	-17,906 Reduced 8.48%	193,278 $208,000
Q2 2023 Aug 10, 2023	SELL	$1.12 - $1.82 $442 - $718	-395 Reduced 0.19%	211,184 $272,000
Q1 2023 May 09, 2023	BUY	$1.25 - $2.0 $69,862 - $111,780	55,890 Added 35.9%	211,579 $279,000
Q4 2022 Feb 08, 2023	BUY	$0.67 - $11.9 $4,170 - $74,065	6,224 Added 4.16%	155,689 $233,000
Q3 2022 Nov 04, 2022	BUY	$1.1 - $12.2 $154,770 - $1.72 Million	140,700 Added 1605.25%	149,465 $175,000
Q2 2022 Jul 29, 2022	SELL	$0.67 - $3.19 $55,245 - $263,034	-82,456 Reduced 90.39%	8,765 $9,000
Q1 2022 May 05, 2022	BUY	$2.22 - $3.45 $25,858 - $40,185	11,648 Added 14.64%	91,221 $272,000
Q4 2021 Jan 21, 2022	SELL	$2.36 - $3.57 $11,507 - $17,407	-4,876 Reduced 5.77%	79,573 $210,000
Q2 2021 Aug 04, 2021	SELL	$3.09 - $4.54 $534,733 - $785,660	-173,053 Reduced 67.2%	84,449 $365,000
Q1 2021 May 10, 2021	SELL	$3.35 - $4.93 $1.15 Million - $1.69 Million	-342,444 Reduced 57.08%	257,502 $879,000
Q4 2020 Feb 08, 2021	SELL	$2.35 - $3.74 $776,914 - $1.24 Million	-330,602 Reduced 35.53%	599,946 $2.1 Million
Q3 2020 Nov 09, 2020	BUY	$1.78 - $4.13 $537,556 - $1.25 Million	301,998 Added 48.05%	930,548 $2.23 Million
Q2 2020 Aug 05, 2020	BUY	$1.41 - $2.05 $233,761 - $339,865	165,788 Added 35.83%	628,550 $1.15 Million
Q1 2020 May 06, 2020	BUY	$1.27 - $3.0 $540,209 - $1.28 Million	425,362 Added 1137.33%	462,762 $719,000
Q4 2019 Jan 29, 2020	SELL	$1.6 - $2.43 $100,640 - $152,847	-62,900 Reduced 62.71%	37,400 $79,000
Q3 2019 Nov 01, 2019	SELL	$1.63 - $2.62 $61,061 - $98,147	-37,461 Reduced 27.19%	100,300 $188,000
Q2 2019 Aug 09, 2019	BUY	$2.02 - $2.61 $215,859 - $278,907	106,861 Added 345.83%	137,761 $359,000
Q1 2019 May 13, 2019	BUY	$2.0 - $2.65 $61,800 - $81,885	30,900 New	30,900 $80,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.81B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account